Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid

被引:5
|
作者
Meshanni, Jaclynn A. [1 ]
Lee, Jordan M. [1 ]
Vayas, Kinal N. [1 ]
Sun, Rachel [1 ]
Jiang, Chenghui [1 ]
Guo, Grace L. [1 ]
Gow, Andrew J. [1 ]
Laskin, Jeffrey D. [2 ]
Laskin, Debra L. [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth & Justice, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
PULMONARY INJURY; BILE-ACIDS; MACROPHAGE ACTIVATION; LIPID HOMEOSTASIS; REACTIVE OXYGEN; KAPPA-B; ATTENUATION; MICE; DISRUPTION; MECHANISMS;
D O I
10.1124/jpet.123.001557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitrogen mustard (NM) is a cytotoxic vesicant known to cause pulmonary injury that can progress to fibrosis. NM toxicity is associated with an influx of inflammatory macrophages in the lung. Farnesoid X receptor (FXR) is a nuclear receptor involved in bile acid and lipid homeostasis that has anti-inflammatory activity. In these studies, we analyzed the effects of FXR activation on lung injury, oxidative stress, and fibrosis induced by NM. Male Wistar rats were exposed to phosphate-buffered saline (vehicle control) or NM (0.125 mg/kg) by intratracheal Penncentury-MicroSprayer aerosolization; this was followed by treatment with the FXR synthetic agonist, obeticholic acid (OCA, 15 mg/kg), or vehicle control (0.13-0.18 g peanut butter) 2 hours later and then once per day, 5 days per week thereafter for 28 days. NM caused histopathological changes in the lung, including epithelial thickening, alveolar circularization, and pulmonary edema. Picrosirius red staining and lung hydroxyproline content were increased, indicative of fibrosis; foamy lipid-laden macrophages were also identified in the lung. This was associated with aberrations in pulmonary function, including increases in resistance and hysteresis. Following NM exposure, lung expression of HO-1 and iNOS, and the ratio of nitrates/nitrites in bronchoalveolar lavage fluid (BAL), markers of oxidative stress increased, along with BAL levels of inflammatory proteins, fibrinogen, and sRAGE. Administration of OCA attenuated NM-induced histopathology, oxidative stress, inflammation, and altered lung function. These findings demonstrate that FXR plays a role in limiting NM-induced lung injury and chronic disease, suggesting that activating FXR may represent an effective approach to limiting NM-induced toxicity.
引用
收藏
页码:586 / 595
页数:10
相关论文
共 50 条
  • [31] THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC
    Kowdley, Kris V.
    Luketic, Velimir A.
    Jones, David E.
    Chapman, Roger W.
    Burroughs, Andrew K.
    Hirschfield, Gideon M.
    Poupon, Raoul
    Schramm, Christoph
    Vincent, Catherine
    Rust, Christian
    Pares, Albert
    Mason, Andrew L.
    Castelloe, Erin N.
    Sciacca, Cathi I.
    Boehm, Olaf
    Pruzanski, Mark
    Shapiro, David A.
    HEPATOLOGY, 2011, 54 : 416A - 417A
  • [32] Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis
    Khan, Md. Abdul Hye
    Nolan, Benjamin
    Stavniichuk, Anna
    Merk, Daniel
    Imig, John D.
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [33] Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis
    Adorini, Luciano
    Rigbolt, Kristoffer
    Feigh, Michael
    Roth, Jonathan
    Erickson, Mary
    PLOS ONE, 2024, 19 (04):
  • [34] FURTHER INCREASE IN BILIARY EXCRETION OF ASYMMETRIC DIMETHYLARGININE DURING HEPATIC ISCHEMIA/REPERFUSION INJURY BY OBETICHOLIC ACID, A FARNESOID-X-RECEPTOR AGONIST
    Di Pasqua, L. G.
    Berardo, C.
    Rizzo, V.
    Adorini, L.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E55 - E55
  • [35] A LONG TERM SAFETY EXTENSION TRIAL OF THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) AND UDCA IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Hirschfield, Gideon M.
    Mason, Andrew L.
    Gordon, Stuart C.
    Luketic, Velimir A.
    Mayo, Marlyn
    Vincent, Catherine
    Lindor, Keith D.
    Pares, Albert
    Kowdley, Kris V.
    Trauner, Michael
    Esguerra, Maria
    Boehm, Olaf
    Shapiro, David A.
    HEPATOLOGY, 2011, 54 : 429A - 429A
  • [37] THE FARNESOID-X-RECEPTOR AGONIST OBETICHOLIC ACID FURTHER INCREASES BILIARY EXCRETION OF ASYMMETRIC DIMETHYLARGININE DURING HEPATIC ISCHEMIA/REPERFUSION INJURY
    Di Pasqua, L. G.
    Berardo, C.
    Rizzo, V.
    Adorini, L.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S315 - S315
  • [38] Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta - A study on maternal cholestasis model
    Wu, W. -B.
    Xu, Y. -Y.
    Cheng, W-W
    Wang, Y. -X.
    Liu, Y.
    Huang, D.
    Zhang, H. -J.
    PLACENTA, 2015, 36 (05) : 545 - 551
  • [39] Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3
    Fan, Yuan-Yuan
    Ding, Wen
    Zhang, Cheng
    Fu, Lin
    Xu, De-Xiang
    Chen, Xi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [40] Activation of Farnesoid X Receptor by Schaftoside Ameliorates Acetaminophen-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammation
    Liu, Meijing
    Zhang, Guohui
    Song, Meng
    Wang, Jueyu
    Shen, Chuangpeng
    Chen, Zhao
    Huang, Xingan
    Gao, Yong
    Zhu, Chenchen
    Lin, Chaozhan
    Mi, Suiqing
    Liu, Changhui
    ANTIOXIDANTS & REDOX SIGNALING, 2020, 33 (02) : 87 - 116